Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the efficacy and safety of Zenapax in combination with CellCept, cyclosporine, and corticosteroids in heart transplant recipi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• CYCLOSPORINE (cyclosporine)
• Corticosteroids (corticosteroids)
• Zenapax (daclizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Heart Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2016-06-13